Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Mar;158(3):1101-9.
doi: 10.1016/S0002-9440(10)64057-6.

Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease

Affiliations
Comparative Study

Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease

M Zareie et al. Am J Pathol. 2001 Mar.

Abstract

Intestinal immune cells are less reactive than those in the peripheral blood; however, such cells from patients with Crohn's disease may be more responsive to bacterial products. Our study examined if nonpathogenic bacteria or lipopolysaccharide (LPS), can affect epithelial function in the presence of monocytes/macrophages. Lamina propria mononuclear cells (LPMCs) and peripheral blood monocytes (PBMs) were obtained from patients with Crohn's disease and control patients. Filter-grown T84 epithelial monolayers were co-cultured with nonactivated or LPS-activated LPMCs or PBMs for 48 hours. Epithelial secretory [baseline short-circuit current (Isc) and DeltaIsc to forskolin] and barrier (transepithelial electrical resistance) parameters were measured in Ussing chambers. LPS-activated PBMs from both controls and patients with Crohn's disease significantly increased Isc ( approximately 300%) and reduced transepithelial electrical resistance ( approximately 40%). Epithelial function was not altered after co-culture with control LPMCs +/- LPS. However, LPMCs from patients with Crohn's disease spontaneously secreted tumor necrosis factor-alpha, and induced epithelial changes similar to those produced by LPS-activated PBMs. Co-culture with control Escherichia coli and PBMs induced comparable changes in epithelial physiology, which were abrogated by anti-tumor necrosis factor-alpha antibody. We conclude that LPMCs of patients with Crohn's disease are spontaneously activated, possibly by gram-negative luminal bacteria, and can directly cause significant alterations in epithelial ion transport and barrier functions.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percent changes from control values (T84 cells alone) in epithelial baseline Isc (A), ΔIsc in response to forskolin (FSK) (B), and transepithelial resistance (C) of T84 monolayers after 48 hours of co-culture with normal or Crohn’s disease (CD) PBMs in the presence or absence of LPS (n = 12 to 14 donors) [mean ± SEM, two to four monolayers per condition; *, P < 0.05 and **, P < 0.005 compared to control (100%)].
Figure 2.
Figure 2.
Basal (−LPS) or stimulated (+LPS) TNF-α production by PBMs (A) and LPMCs (B) from normals or patients with Crohn’s disease (CD) after 24 hours of co-culture (n = 6 to 8 donors). Each symbol represents an individual cell donor.
Figure 3.
Figure 3.
Percent changes from control values (T84 cells alone) in epithelial baseline Isc (A), ΔIsc in response to forskolin (FSK) (B), and transepithelial resistance (C) of T84 monolayers after 48 hours of co-culture with normal or Crohn’s disease LPMCs in the presence or absence of LPS (n = 8 to 10 specimens per condition). Data for small bowel (SB) and large bowel (LB) are shown separately and combined as Crohn’s total; statistical analyses performed on grouped Crohn’s total data only [mean ± SEM, two to four monolayers per condition; *, P < 0.05 and **, P <0.005 compared to control (100%); control values: baseline Isc range = 0 to 6 (mean, 2.4) μA/cm2; ΔIsc to FSK range = 30 to 154 (mean, 70) μA/cm2; TER range = 770 to 3,333 (mean, 1,784) Ω/cm2].
Figure 4.
Figure 4.
Percent changes from control values (T84 cells alone) in epithelial secretory responses; baseline Isc (A) and ΔIsc in response to forskolin (FSK) (B) of T84 monolayers after 48 hours of co-culture with control E. coli alone or E. coli and PBMs in the presence or absence of anti-TNF-α antibody (aTNF-α) (n = 6 to 8 donors) [mean ± SEM, two to four monolayers per condition; *, P < 0.05 compared to control (100%); control values: baseline Isc range = 1 to 3 (mean, 1.4) μA/cm2; ΔIsc to FSK range = 66 to 118 (mean, 92) μA/cm2].
Figure 5.
Figure 5.
Changes from control values (T84 cells alone) in epithelial barrier function measured by transepithelial resistance (A) and mucosal-to-serosal flux of 51Cr-EDTA across T84 monolayers (B) after 48 hours of co-culture with control E. coli alone or E. coli and PBMs in the presence or absence of anti-TNF-α antibody (aTNF-α) (n = 6 to 8 donors) [mean ± SEM, two to four monolayers per condition; *, P < 0.05 compared to control (100%); control TER range = 860 to 1,620 (mean, 1,093) Ω/cm2].

References

    1. Duchmann R, Schmitt E, Knolle P, Buschenfelde KMZ, Neurath M: Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996, 26:934-938 - PubMed
    1. MacDonald TT: Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease. Clin Exp Immunol 1995, 102:445-447 - PMC - PubMed
    1. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274 - PubMed
    1. Targan S, Deem RL, Liu M, Wang S, Nel A: Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995, 154:664-675 - PubMed
    1. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer Zum KH: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 102:448-455 - PMC - PubMed

Publication types

MeSH terms

Substances